Saving women's lives: Evidence-based recommendations for the prevention of postpartum haemorrhage

Bulletin of the World Health Organization

Volumn 85, Issue 4, 2007, Pages 322-323

  Mathai, Matthews ^a   Gülmezoglu, A Metin ^a   Hill, Suzanne ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOMETRINE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN DERIVATIVE; UTEROTONIC AGENT; OXYTOCIC AGENT;

DISEASE CONTROL; HEALTH SERVICES; REPRODUCTIVE DISORDER; WOMENS HEALTH;

CHILDBIRTH; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; DISEASE SEVERITY; DOSE RESPONSE; DRUG COST; DRUG FORMULATION; ENVIRONMENTAL TEMPERATURE; EVIDENCE BASED MEDICINE; HEALTH CARE FACILITY; HEALTH SURVEY; HUMAN; INTERVENTION STUDY; LABOR; MATERNAL CARE; MATERNAL MORTALITY; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL INFORMATION; POSTPARTUM HEMORRHAGE; PREVENTIVE HEALTH SERVICE; PROPHYLAXIS; RISK FACTOR; SHORT SURVEY; UNSPECIFIED SIDE EFFECT; UTERUS CONTRACTION; VAGINAL DELIVERY; ARTICLE; CHEMISTRY; DRUG STABILITY; FEMALE; HEALTH SERVICE; HEAT; ORGANIZATION AND MANAGEMENT; WOMEN'S HEALTH; WORLD HEALTH ORGANIZATION;

DRUG STABILITY; EVIDENCE-BASED MEDICINE; FEMALE; HEAT; HUMANS; MATERNAL HEALTH SERVICES; OXYTOCICS; POSTPARTUM HEMORRHAGE; WOMEN'S HEALTH; WORLD HEALTH ORGANIZATION;

EID: 34147117258     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.07.041962     Document Type: Short Survey

References (16)

1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
2. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000;CD000007.
3. Managing complications in Pregnancy and Childbirth. Geneva: WHO; 2000.
4. Hogerzeil HV, Walker GJ. Instability of (methyl)ergometrine in tropical climates: an overview. Eur J Obstet Gynecol Reprod Biol 1996;69:25-9.
5. Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 2005;112:547-53.
6. Jadesimi A, Okonofua FE. Tackling the unacceptable: Nigeria approves misoprostol for postpartum haemorrhage. J Fam Plann Reprod Health Care 2006;32:213-4.
7. Guidelines for pregnancy care and management of common obstetric complications by medical officers. New Delhi: Ministry of Health and Family Welfare, Government of India; 2005.
8. McCormick ML, Sanghvi HC, Kinzie B, McIntosh N. Preventing postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet 2002;77:267-75.
9. Potts M, Prata N, Walsh J, Grossman A. Parachute approach to evidence based medicine. BMJ 2006;333:701-3.
10. Sanghvi H, Wiknjosastro G, Chanpong G, Fishel J, Ahmed S, Zulkarnain M. Prevention of postpartum hemorrhage study, West Java, Indonesia. Baltimore, JHPIEGO/Johns Hopkins University; 2004.
11. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
12. de Groot ANJA. The role of oral (methyl)ergometrine in the prevention of postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 1996;69:31-6.
13. WHO recommendations for the prevention of postpartum haemorrhage. Geneva: WHO; 2007.
14. Facility-based management of the third stage of labor and community perceptions and actions on postpartum hemorrhage: findings from a national survey in Ethiopia. Washington: Prevention of Postpartum Hemorrhage Initiative (POPPHI); 2006.
15. Facility-based management of the third stage of labor and community perceptions and actions on postpartum hemorrhage: findings from a national survey in Tanzania. Washington: Prevention of Postpartum Hemorrhage Initiative (POPPHI); 2006.
16. Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006;368:1248-53.